BIIB

Biogen Inc (NASDAQ: BIIB) Q2 2021 Earnings Conference

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for…

Biogen Inc. (NASDAQ: BIIB) Q1 2021 earnings call dated Apr. 22, 2021 Corporate Participants: Mike Hencke — Director of Investor Relations Michel…

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today. Total revenues decreased 24% year-over-year to $2.6 billion. On…

Biogen Inc (NASDAQ: BIIB) Q1 2021 Earnings Conference

Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke — Director, Investor Relations Michel Vounatsos — Chief Executive…

Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke — Director, Investor Relations Michel Vounatsos — Chief…

Biogen (NASDAQ: BIIB) reported fourth-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 22%…

The controversy surrounding biotechnology firm Biogen’s (NASDAQ: BIIB) Alzheimer’s drug Aducanumab took a positive turn last week after the FDA…

Biogen Inc. (NASDAQ: BIIB) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Joe Mara — Head of Investor Relations Michel Vounatsos — Chief…